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Summary A myoepithelial cell line (PA 16/23) was derived from a pleomorphic adenoma of the parotid
gland. PA 16/23 cells have light microscopic, immunophenotypical and ultrastructural features of immature
myoepithelial cells, i.e. they are of fusiform or stellate shape and show keratin and actin cytofilaments located
mainly in the perinuclear cytoplasm, desmosomes and tracts of basal lamina. The PA 16/23 cells grew actively
and expressed mRNA for and produced interleukin 6 (IL-6) which was released into the culture medium. This
cytokine, in turn, acted as an autocrine growth factor on the cells. PA 16/23 cells also expressed high-affinity
IL-6 receptors. In these cells, both IL-6 production and proliferation could be modulated by exogenous
stimulants, such as IL-6 itself, IL-I, IL-4, tumour necrosis factor ac, interferon y and lipopolysaccharide. From
the 40th culture passage onwards, the PA 16/23 cells ceased to grow, either spontaneously or in response to
exogenous stimulants. Moreover, they strongly reduced IL-6 production, and underwent morphological
differentiation into more mature myoepithelial cells, with an increased amount and a different arrangement of
the keratin and actin cytofilaments, which formed thick bundles in the peripheral cytoplasm. These findings
suggest a role for IL-6 in modulating the proliferation and, possibly, the differentiation of the PA 16/23 cells.
There is increasing evidence that cell growth is regulated by
the dual action of growth-promoting and growth-inhibiting
signals provided by both cell contact and secreted proteins
(reviewed in Druker et al., 1989; Aaronson, 1991; Cross &
Dexter, 1991). Recently, attention has been focused on inter-
leukin 6 (IL-6), a pleotropic cytokine produced by a variety
of normal cells (May et al., 1988; Tosato & Pike, 1988;
Tosato et al., 1988; Kirnbauer et al., 1989; Sironi et al., 1989;
Tabibzadeh et al., 1989a, Hirano et al., 1990; Nabata et al.,
1990; Shirota et al., 1990), as well as by several tumours and
tumour cell lines (van Damme et al., 1987; Yasukawa et al.,
1987; Kirnbauer et al., 1989; Miki et al., 1989; Tabibzadeh et
al., 1989b; Hirano et al., 1990; Jourdan et al., 1990; Kasa-
hara et al., 1990; Navarro et al., 1990; Gallo et al., 1992;
Koo et al., 1992). IL-6 acts on a wide range of tissues and
cells, exerting growth-inhibiting or growth-inducing effects,
depending on the nature of the target cells (Lee et al., 1989;
Hirano et al., 1990; Revel et al., 1990a,b; Brach & Herrmann,
1992). Moreover, it has recently been shown that IL-6 also
plays a major role in controlling the differentiation of several
cell types, including embryonic cells (Lee et al., 1989;
Navarro et al., 1990; Revel et al., 1990b; Romero et al., 1990;
Krueger et al., 1991).
We have recently described a myoepithelial cell line (PA
16/23), derived from a pleomorphic adenoma of the parotid
gland, which apparently uses IL-6 as an autocrine growth
factor (Gallo et al., 1992). In the presently described study,
further morphological features and functional properties of
PA 16/23 cells were assessed. Moreover, it was found that
spontaneous in vitro differentiation of the cell line to a
mature myoepithelial phenotype was accompanied by reduc-
tion of growth, decreased production of IL-6 and lack of
responsiveness to exogenous IL-6.
Materials and methods
Cell cultures
The PA 16/23 cells were grown in Coon's modified Ham F12
medium on Falcon plastic tissue culture dishes, and plated at
1-5 x 106 cells cm-2. The cultures were incubated at 37°C in
a 5% carbon dioxide incubator. Once the cells of a given
culture passage had reached confluence, they were split into
two new subcultures. In this way, every culture passage
roughly corresponds to the doubling time of the cells. Phase-
contrast photomicrographs were taken at intervals of 1 week
from the tenth passage onwards.
Immunocytochemical analysis
Immunocytochemical analysis was performed on the PA 16/
23 cells at the tenth and 40th passages. The cells were grown
on glass slides for 48 h, fixed in 4% paraformaldehyde in
0.1 M Tris-buffered saline (TBS), pH 7.4, for 30 min at room
temperature, rinsed in the same buffer and air dried. The
primary antisera used were anti-pancytokeratin (AE-3,
Ortho, Raritan, NJ, USA), and anti-x smooth muscle actin
(Sigma, St Louis, MO, USA). Immune reaction was revealed
by the alkaline phosphatase-anti-alkaline phosphatase
(APAAP) method (Cordell et al., 1984). New fuchsin (Sigma)
was used as chromogen and, finally, specimens were counter-
stained with Mayer's haemalum, dehydrated in ethanol and
mounted in Permount. Negative controls were performed by
replacing the primary antiserum with non-immune mouse
serum.
Electron and immunoelectron microscopy
PA 16/23 cells at the 15th and 40th passages were gently
detached from Petri dishes with a rubber scraper and pelleted
by centrifugation at 1,000 r.p.m. The pellets were fixed in
cold 4% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4,
for 3 h at room temperature. For conventional electron
microscopy, some of the pellets were post-fixed in cold 1%
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osmium tetroxide in 0.1 M sodium phosphate buffer, pH 7.4,
at 4°C; for immunoelectron microscopy, this step was omit-
ted. All the specimens were dehydrated in graded acetone,
passed through propylene oxide and embedded in Epon 812.
For immunoelectron microscopy, a post-embedding proce-
dure was used according to Varndell et al. (1982), with minor
modifications. Briefly, ultrathin sections from non-osmicated
samples were collected on uncoated nickel grids. After
etching of the epoxy resin with 30% hydrogen peroxide, the
sections were incubated with rabbit polyclonal anti-rIL-6
serum (Genzyme, Boston, MA, USA) diluted in 0.1 M TBS,
pH 7.4, to a protein concentration of 25tLg ml-', and then
incubated with goat anti-rabbit immunoglobulins conjugated
with 5 nm colloidal gold particles (Janssen, Beerse, Belgium).
Negative controls were performed by replacing anti-IL-6
serum with either non-immune rabbit serum or anti-IL-6
serum preabsorbed with rIL-6. Ultrathin sections were
counterstained with uranyl acetate and lead citrate, and
examined in a Siemens Elmiskop 102 electron microscope at
80 kV.
Stimulants
Human recombinant interferon e (rIFN-7) was kindly pro-
vided by Biogen (Geneva, Switzerland); human recombinant
interleukin 4 (rIL-4) was kindly provided by Unicet
(Schering-Plough, France); human recombinant IL-6 (rIL-6),
human recombinant interleukin 1 (rIL-I) and human recom-
binant tumour necrosis factor a (TNF-a) were purchased
from British Biotechnology Limited (Oxford, UK). Lipo-
polysaccharide (LPS) from Escherichia coli 0128:B12 was
purchased from Sigma. Conditioned medium of the actively
proliferating PA 16/23 cells, containing high levels of
immunodetectable IL-6, was also collected and used as
stimulant.
Assayfor IL-6production by the PA 16/23 cells under
different stimuli
PA 16/23 cells (1 x 106 per vial) at the tenth passage were
incubated for 24h in RPMI-1640 medium (Flow Labora-
tories, McLean, VA, USA) supplemented with 10% fetal calf
serum (FCS) (Hyclone Lab, Logan, UT, USA) in the absence
or presence of the different cytokines, or of LPS. The cells
were then centrifuged at 1,000 r.p.m. for 10 min and culture
supernatants were collected, filtered through a 0.22,m filter
and then stored in aliquots at - 70°C until needed. The same
procedure was also applied to PA 16/23 cells at the 40th
passage stimulated with increasing rIL-6 concentrations.
Quantitative determination of IL-6 was carried out on cul-
ture supernatants of the PA 16/23 cells, at the above pas-
sages, by enzyme-linked immunosorbent assay (ELISA)
(Quantikine, R&D, Minneapolis, MN, USA), according to
the procedure described by Del Prete et al. (1988) for similar
purposes. Culture medium (with and without fetal calf
serum) was used as negative control. For statistical anaylsis,
distribution of the values obtained by measuring IL-6 in the
supernatants was assessed as normal by the x2 test. Then,
significance of the differences between the values of the un-
stimulated and the stimulated cells was evaluated by one-
tailed Student's t-test for paired values. P<0.05 was con-
sidered significant.
RNA extraction and analysis ofIL-6 mRNA bypolymerase
chain reaction
PA 16/23 cells at the 11th and 41st passages were detached
from culture plates and pelleted by centrifugation. Cell pellets
were subjected to RNA extraction by the guanidium isothio-
cyanate-phenol-chloroform procedure. The cDNA was syn-
thesised with avian myeloblastosis virus reverse transcriptase
(Pharmacia, Uppsala, Sweden) and polymerase (dT) (Phar-
macia) priming. Reverse-transcribed total RNA amplification
was carried out by polymerase chain reaction (PCR) in a
buffer containing 50 mM potassium chloride, 10mM Tris-
HCI, pH 8.3, 1.5 mM magnesium chloride, 0.1% (w/v) gela-
tin, 200 M dNTP, 2.5 U of Taq polymerase (Perkin Elmer,
Hayward, CA, USA), and 500pmol of each human IL-6
primer (primer 1, nucleotides 35-57, sense strand; primer 2,
nucleotides 644-667, antisense strand; 628 bp). The reaction
consisted of 30 cycles of denaturation at 94°C for 1 min,
annealing at 70°C for 1 min and extension at 72°C for 2 min.
PCR was done for 30 cycles on the same samples with
synthetic primers for ,-actin (113 bp) as controls. PCR pro-
ducts were analysed by electrophoresis on 2.5% agarose gels
and visualised by ethidium bromide staining.
Analysis ofcellgrowth
The proliferative response to different stimulants of the PA
16/23 cells at the tenth passage was evaluated by the
[3H]thymidine incorporation assay. Briefly, 2 x 105 cells were
cultured for 72 h in RPMI-1640 medium supplemented with
10% adult calf serum in the absence or presence of different
stimulants. Sixteen hours before harvesting, the cells were
pulsed with 0.5 yCi of [3H]thymidine. DNA was precipitated
with 10% trichloroacetic acid and collected on paper filters,
and radioactivity was determined by scintillation counting.
Cell proliferation upon different stimuli was also evaluated
by the bromodeoxyuridine (BrdU) incorporation assay. This
was carried out on cells at the tenth and the 40th passage.
The cells were recovered from the cultures, resuspended in
medium containing 1O 1M BrdU (Sigma), incubated in the
medium for 45 min in a carbon dioxide incubator at 37°C,
washed with 0.1 M phosphate-buffered saline (PBS), pH 7.4,
and fixed in 70% ethanol for 30 min. For immunolabelling,
the cells were removed from the ethanol and incubated in
1 ml of 2 M hydrochloric acid-0.5% Triton X-100 at room
temperature for 30 min. After washing, the cells were
incubated with 0.02 ml of (FITC)-conjugated anti-BrdU
monoclonal antibody (Becton Dickinson) for 30 min at room
temperature. The cells were washed again and resuspended in
1 ml of 0.1 M PBS, pH 7.4, containing 5 mgml-' propidium
iodide (Sigma) in the presence of 7.5 mg of ribonuclease
(Sigma). The number of immunostained cells was determined
by an Ortho Absolute Cytometer.
Surface binding ofradioiodinated IL-6
Confluent PA 16/23 cells at the 12th passage (1 x 106 in
six-well plates) were treated with medium buffered with
isotonic phosphoric acid, pH 3.5, for 1 min at 4°C to elute
endogenous ligand. The supernatant of this incubation is
referred to as acidic eluate; the brief exposure of cultures to
acidic buffer had no effect on cell viability, based on trypan
blue exclusion. Then, cultures were washed in medium con-
taining 10% fetal calf serum and incubated for 2 h at 4°C in
an orbital shaker in 1 ml of medium containing different
concentrations of '251-labelled rIL-6 (Amersham, Bucks, UK)
alone or in the presence of excess unlabelled rIL-6 (Amer-
sham). Monolayers were then washed thoroughly and radio-
activity was determined. The values of the measurements
were analysed by a scientific data analysis program (Enz-
fitter-Biosoft, Cambridge, UK) to determine the constant of
dissociation (Kd) of the reaction and number of receptor
molecules per cell.
Results
Behaviour ofthe PA 16/23 cells at different passages
The PA 16/23 cells could be grown in minimal medium
conditions for about 38-40 passages, corresponding to about
9 months in culture. The cells were mostly fusiform or den-
dritic in shape (Figure la), seeded in monolayers, and sub-
confluence was reached every 7 days. A minority of the cells
(approximately 1-2%) had a flattened, roughly polyhedral
shape and larger size. Their cytoplasm appeared to be filled
with bundles of filaments. Starting from the passage 38-40IN VITRO DIFFERENTIATION OF A MYOEPITHELIAL CELL LINE 1067
Figure 1 Phase-contrast featues of PA 16/23 cells in culture. At
the tenth passage, the cells were spindle or star-shaped a, whereas
at the 40th passage they were very large, and their cytoplasms
appeared to be filled with filaments. Bar = 50 tLm.
onwards, a dramatic change in both growth pattern and
morphology of the cell population occurred, despite using the
same culture conditions, glassware and reagents. The cells
ceased to grow, and the large cells with flattened, polyhedral
shape predominated (Figure lb), only a minority of the cells
(approximately 10-15%) maintaining the original fusiform,
dendritic features. The latter cells were usually clustered
together. Time-course microscopic examination of the culture
plates gave the impression that only the fusiform, dendritic
cells were still growing. On the other hand, most of the large,
flattened cells, although apparently not growing, could be
maintained in culture for months, without any sign of death.
Immunocytochemical and ultrastructuralfeatures ofthe PA
16/23 cells
At the tenth passage, the PA 16/23 cells were immunoreactive
for both keratin and actin: keratin filaments were arranged in
a meshwork which was especially dense in the perinuclear
area; actin was distributed mainly in small clusters through-
out the cytoplasm, and only rarely did it form thin, elongated
filaments in the peripheral cytoplasm (Figure 2a and c). At
the 40th passage, the PA 16/23 cells were still immunoreac-
tive for keratin and actin, but the keratin filaments formed a
dense meshwork around the nucleus, with radially orientated
bundles penetrating the peripheral cytoplasm. Actin was also
present in the form of filaments, which were arranged in a
perinuclear network, and in thick, rectilinear bundles reach-
ing the cell periphery (Figure 2b and d). On electron micro-
scopy, clear-cut differences could be observed between the
PA 16/23 cells at the 15th and 40th passages. The cytoplasm
of the former contained several rough endoplasmic reticulum
(RER) cisternae, a well-developed Golgi apparatus and some
cytofilaments, often associated in short, thin bundles with
interspersed dense bodies. Desmosomes joining adjacent cells
and tracts of basal lamina could sometimes be seen (Figure
3a). In contrast, the older cells showed less developed RER
and Golgi apparatus. The cytofilaments were more abundant,
especially contractile microfilaments. They were usually
gathered together to form large bundles, with interspersed
dense bodies, which occupied large areas of the perinuclear
and peripheral cytoplasm. Lysosomes - either primary or
secondary and residual bodies - could often be found in
these cells. Desmosomes and basal lamina were as in the
younger cells (Figure 3b).
Spontaneous and induced IL-6production
IL-6 mRNA was detected by PCR analysis of total cellular
RNA in the PA 16/23 cells at the tenth passage (Figure 4).
The supernatants of the PA 16/23 cells at the same passage
contained large amounts of IL-6 (1,070 ± 120 pgml-'). More-
over, incubating the cells with stimulants known to be able to
modulate IL-6 production in other biological systems caused
an increase in IL-6 content (Table I). Interestingly, addition
of exogenous rIL-6 also resulted in greater amounts of
detectable IL-6 in the supematant (4,333 ± 235 pgml-') than
could be expected by summing the values of spontaneously
secreted (1,070 ± 120pgml-') and exogenously added (800
pgml-') IL-6. In contrast, no IL-6 mRNA could be detected
in the PA 16/23 cells at the 40th passage, although the cells
expressed P-actin mRNA like their younger counterparts
(Figure 4), and the cell supernatants contained very low
levels of IL-6 (260pgml-'). Moreover, addition of rIL-6 at
concentrations of 800, 1,600 and 2,500 pgml-' did not result
in increased levels of immunodetectable IL-6 in the cell
supernatants.
Immunoelectron microscopic detection ofIL-6 in the PA 16/23
cells
IL-6 immunoreactrvity could be detected in the PA 16/23
cells at the 15th passage. The colloidal gold label was
localised into the cisternae of RER, in the saccules of the
Golgi apparatus and, more rarely, even into cytoplasmic
bodies featuring secretion granules. In contrast, no definite
IL-6 immunoreactivity could be detected in the cells at the
40th passage.
Proliferation ofPA 16/23 cells in response to different stimuli
PA 16/23 cells at the tenth passage were assayed for their
proliferative response to different cytokines (Table II). As
expected, rIL-6 was the most effective agent in inducing PA
16/23 cell growth. The other cytokines tested evoked a less
evident proliferative response. The results obtained with the
[3H]thymidine test were paralleled closely by the results of
BrdU incorporation. In contrast, no substantial proliferation
was detected in PA 16/23 cells beyond the 40th passage. In
fact, as shown by BrdU incorporation, spontaneous growth
was very low (only 7% of cultured cells incorporated BrdU).
Moreover, the cells did not respond to addition of either
rIL-6 at concentrations of 800, 1,600 and 2,500pgml1' or
IL-6-rich conditioned medium from actively growing PA
16/23 cells at the tenth passage.1068 0. GALLO et al.
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Figure 2 Immunophenotype of PA 16/23 cells. Less differentiated cells at the tenth passage (left) and more differentiated cells at
the 40th passage (right) show different amounts and distribution patterns of immunoreactive keratin (a and b) and actin (c and d).
Bar = 20 gm.
IL-6 binding to PA 16/23 cells
Since PA 16/23 cells produced IL-6 spontaneously and pro-
liferated in response to exogenous IL-6, it was assumed that
endogenous IL-6 was occupying the high-affinity binding
sites, thus allowing detection of the low-affinity binding sites
only. After elution of the cell surface with acidic buffer to
remove endogenous ligand, binding studies demonstrated
high-affinity binding sites for 1251I-labelled IL-6, with a Kd of
136 pM and 180 sites per cell (Figure 5). After the 38th
passage, insufficient numbers of PA 16/23 cells for binding
studies could be achieved.
Discussion
This study confirms and extends our previous observations
showing that IL-6 is an autocrine growth factor for PA 16/23
cells (Gallo et al., 1992). The findings reported here also
demonstrate that PA 16/23 cells show the morphological
features of immature myoepithelial cells, express high-affinity
IL-6 receptors and re$pond to exogenous rIL-6 by increasing
their growth rate. Moreover, exogenous stimulants known to
be able to control IL-6 production in other biological systems
(Zilberstein et al., 1986; Walther et al., 1988) appeared to be
active on the PA 16/23 cells by modulating IL-6 release and
cell growth. However, from the 40th culture passage on-
wards, the PA 16/23 cells acquired ultrastructural and
immunophenotypical characteristics of mature myoepithelial
cells, showed a dramatic decrease in IL-6 production and
release, and no longer responded to exogenous IL-6 (either
recombinant peptide or culture supernatants from undiffer-
entiated cells). It is well known that many cell cultures
undergo a growth crisis after several passages, and it is a
common experience to see, at that stage, very large cells
containing bundles of cytofilaments. This phenomenon has
not yet been explained satisfactorily, and it is still matter of
debate whether it represents true differentiation or rather cell
senescence (Downes, 1993). Taken together, the present
findings strongly support the view that the PA 16/23 cells
really underwent spontaneous in vitro differentiation. In fact,
these cells changed their features, showing strong actin
immunoreactivity and conspicuous bundles of microfilaments
with interspersed dense bodies, which are typical of differ-
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Figure 5 IL-6 binding by PA 16/23 cells at the 12th passage.
Saturation curve at equilibrium (upper) and Scatchard represen-
tation (below) of the specific binding.
Table I Spontaneous and stimulated production ofIL-6 by PA 16/23
cells at the tenth passagea
IL-6 levels Significance
Stimulants Concentration (pgml-') vs unstimulated
None 1,070+ 120
IL-6 800 pgml-' 4,333+235 P<<0.001
IL-l 10 ngml-' 4,400+242 P<<0.001
TNF-a 500Uml-' 3,300±168 P<<0.001
IFN-y 500 Uml-' 2,333± 178 P<0.005
IL-4 200 Uml-' 1,620± 112 P<0.02
LPS lojigml- 1,100+99 NS
aThe IL-6 values represent the mean± s.e.m. of three separate
experiments. NS, not significant.
Figure 3 Electron microscopy of PA 16/23 cells. Less different-
iated cells at the 15th passage a, show several RER cisternae,
well-developed Golgi apparatus and sparse cytofilament bundles.
More differentiated cells at the 40th passage b, show less
developed endoplasmic reticulum and Golgi apparatus, and more
abundant cytofilaments, which form dense bundles in the peri-
pheral cytoplasm. Bar = 1 jim. Inset: detail of a bundle of
contractile microfilaments with interspersed dense bodies. Bar=
500 nm.
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5
628 pb
113 bp p - - - Acti n
Figure 4 PCR analysis for I3-actin and IL-6 mRNA from PA
16/23 cells. Lane 1, marker, PUC 19; lanes 2 and 3, control:
amplification cDNA bands from P-actin mRNA in the cells at the
11th and 41st culture passage, respectively; lane 4, an ampli-
fication cDNA band from IL-6 mRNA in the cells at the 11th
culture passage; lane 5, no IL-6 mRNA can be found in the cells
at the 41st culture passage.
entiated cells with contractile function, including myo-
epithelial cells. Moreover, the differentiated PA 16/23 cells,
like their less differentiated counterparts, expressed P-actin
mRNA, thus indicating that they are actively engaged in the
synthesis of a structural protein, at variance with senescent
cells, which usually have a poor metabolism. Finally, most
PA 16/23 cells did not show signs of degeneration or death
but, rather, were able to grow again when co-cultured with
Table II Effects ofdifferent cytokines on theproliferation ofPA 16/23
cells at the tenth passagea
Cytokine 3H-Thy uptake BrdU incorporation
added Concentration (stimulation index)b (% positive cells)
None - 32
IFN-7 500 Uml-' 1.97 54
IL-I 10ngml-' 2.15 54
TNF-a 500 Uml-' 2.55 56
IL-4 1000 Uml-' 2.6 50
IL-6 800 pgml-' 3.3 73
aThevalues represent themean ±s.e.m. ofthree separateexperiments.
bStimulation index: c.p.m. in the stimulated cultures/c.p.m. in the
unstimulated cultures.
mammary tumour cells, joining together with the latter cells
(manuscript in preparation). In addition, the current findings
show that differentiation of PA 16/23 cells into a mature
phenotype paralleled a strong reduction of their growth rate
and decreased production of the autocrine growth factor
IL-6.
Whether the decline of IL-6 expression is causally related
to the onset of cell differentiation or is a consequence of it
remains to be established. However, it is tempting to
speculate that inactivation of IL-6-encoding genes, and
presumably of genes encoding for its receptor, is a crucial
event in the differentiation process of the PA 16/23 cells,
whereas expression of the same genes is closely related to PA
16/23 cell proliferation. Going a step further, it may be
possible that derangement of mechanisms controlling the
expression of IL-6 and IL-6 receptor genes in cells of the
salivary glands plays a major role in the generation of the
transformed phenotype, and hence in the development of
pleomorphic adenoma. It is noteworthy that pleomorphic
adenoma is thought to arise from transformed myoepithelial
cells or precursors common to both epithelial and myo-
epithelial cells (reviewed in Gallo et al., 1992). This origin
accounts for the unique histopathological features of the
tumour, in which areas made up of more undifferentiated,
spindle-shaped cells coexist with areas showing clear-cut
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glandular differentiation and easily distinguishable epithelial
and myoepithelial cells (Dardick et al., 1983). Thus, the
ability of the PA 16/23 cells to differentiate in vitro into
mature myoepithelial cells closely resembles the spontaneous
in vivo attitude of the precursor cell to pleomorphic adenoma
to give rise to more differentiated cells.
Recent studies suggest that activation of IL-6 gene is under
the control of oncogenes. In fact, transfection of p53 mutated
oncogene in HeLa cells greatly increases IL-6 mRNA (San-
thanam et al., 1991). Overexpression of p53 oncoprotein has
also been found in cells from primary cultures of pleomor-
phic adenomas (Azuma et al., 1992). The findings reported
here showing that IL-6 has a key role in controlling prolifera-
tion of pleomorphic adenoma cells suggest a possible inter-
play between the two events in the generation of the trans-
formed phenotype of pleomorphic adenoma cells. The above
hypothesis is currently under investigation in our laboratory.
In particular, the possibility of a simultaneous expression of
altered p53 oncoprotein and IL-6 in PA 16/23 cells and in
tissue specimens and primary cultures from pleomorphic
adenoma of the parotid gland is being investigated.
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